Musculoskeletal DiseasesNCT05639296
Expert Learning in Musculoskeletal Ultrasound
An observational study of Musculoskeletal Diseases, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Spain.
Trial summary
Musculoskeletal ultrasound (MSUS) is a complex procedure and requires lifelong theoretical and practical training to ensure continued professional development. Currently, the teaching approach for experts in MSUS is theoretical preparation first and then hands-on training, the "Tell-Then-Do" approach. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Musculoskeletal Diseases
- What is being tested?
- Discovery learning (DL)
- How many people
- 38 participants
- Where
- 1 siteSpain
- Study dates
- 25 Jan 2023to 30 Jan 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Physicians with a Rheumatology background. All experts in the field of MSUS.
Who may be able to join
- Experts in MSUS, defined as physicians who have performed more than 1000 MSUS examinations
Who cannot join
- Physicians who have not performed 1000 MSUS examinations.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Expert Learning in Musculoskeletal Ultrasound - the Effect of Discovery Learning
Musculoskeletal ultrasound (MSUS) is a complex procedure and requires lifelong theoretical and practical training to ensure continued professional development.
Currently, the teaching approach for experts in MSUS is theoretical preparation first and then hands-on training, the "Tell-Then-Do" approach. The existing literature on optimizing training for experts is sparse, and it is unknown if the training intervention Discovery Learning could be a more effective teaching method for this group of learners.
- Conditions
- Musculoskeletal Diseases
- Being tested
- Discovery learning (DL)
- Keywords
- Medical education, Ultrasound
- Medical subject headings
- Musculoskeletal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Discovery learning (DL)Other
DL makes the trainee practice before giving them instruction, "Do-Then-Tell", thereby promoting their ability to use and build upon their existing knowledge.
| Study group | Role | What they receive |
|---|---|---|
| MSUS experts | Physicians with extensive experience with MSUS (performed more than 1000 examinations). Receives: Other: Discovery learning (DL) |
What is being measured
The primary outcome is the main question the study is designed to answer.
How do experts in MSUS approach a new and unfamiliar MSUS task?
All performances will be analyzed to examine how the experts solve the MSUS case, e.g., do they use the available material etc? More specifically, how much time (in seconds) do they use on different problem-solving methods such as "information seeking", "trial and error", and "systematic evaluation".
Measured: January 2023
Secondary outcomes (1)
How do the experts respond to DL?
i.e., are they comfortable changing the learning situation from "Tell-Then-Do" to "Do-Then-Tell"? The participants will fill out a post-course questionnaire. 10 questions to be answered on a 5 point Likert scale from (range 1-5).
Measured: January 2023
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Dec 2022
- Study start25 Jan 2023
- Primary completion26 Jan 2023
- Study completion30 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Musculoskeletal DiseasesStudies of the same condition, open and under way.
- More trials run by Copenhagen University Hospital, RigshospitaletThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 38 participants (actual)
Sponsor and investigators
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Stine Maya Dreier Carstensen, Copenhagen University Hospital, Rigshospitalet
- Investigators
- Stine Maya Dreier Carstensen, MD, Principal investigator, COPECARE (Copenhagen Center for Arthritis Research) Rigshospitalet, Glostrup
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05639296
- Sponsor's protocol ID
- 2023-004
- Status last verified
- Apr 2023
- First submitted
- 22 Nov 2022
- Last updated
- 1 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Brydges R, Fiume A, Grierson L. Mastery versus invention learning: impacts on future learning of simulated procedural skills. Adv Health Sci Educ Theory Pract. 2022 May;27(2):441-456. doi: 10.1007/s10459-022-10094-x. Epub 2022 Mar 23.
PubMed 35320441Steenhof N, Woods NN, Van Gerven PWM, Mylopoulos M. Productive failure as an instructional approach to promote future learning. Adv Health Sci Educ Theory Pract. 2019 Oct;24(4):739-749. doi: 10.1007/s10459-019-09895-4. Epub 2019 May 14.
PubMed 31089856Terslev L, Hammer HB, Torp-Pedersen S, Szkudlarek M, Iagnocco A, D'Agostino MA, Schmidt WA, Uson J, Bruyn GA, Filippucci E, Moller I, Balint P, Wakefield R, Naredo E. EFSUMB minimum training requirements for rheumatologists performing musculoskeletal ultrasound. Ultraschall Med. 2013 Oct;34(5):475-7. doi: 10.1055/s-0033-1335143. Epub 2013 May 21.
PubMed 23696065
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Expert Learning in Musculoskeletal Ultrasound - the Effect of Discovery Learning
- ClinicalTrials.gov ID
- NCT05639296
- Acronym / sponsor ID
- 2023-004
- Conditions
- Musculoskeletal Diseases
- Keywords
- Medical education, Ultrasound
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 38 participants (actual)
- Lead sponsor
- Copenhagen University Hospital, RigshospitaletUniversity, hospital or other
- Study start
- 25 Jan 2023 (actual)
- Primary completion
- 26 Jan 2023 (actual)
- Study completion
- 30 Jan 2023 (actual)
- First posted
- 6 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Musculoskeletal ultrasound (MSUS) is a complex procedure and requires lifelong theoretical and practical training to ensure continued professional development.
Currently, the teaching approach for experts in MSUS is theoretical preparation first and then hands-on training, the "Tell-Then-Do" approach. The existing literature on optimizing training for experts is sparse, and it is unknown if the training intervention Discovery Learning could be a more effective teaching method for this group of learners.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| MSUS experts | – | Other: Discovery learning (DL)Physicians with extensive experience with MSUS (performed more than 1000 examinations). |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Physicians with a Rheumatology background. All experts in the field of MSUS.
Key inclusion criteria (1 listed)
- Experts in MSUS, defined as physicians who have performed more than 1000 MSUS examinations
Key exclusion criteria (1 listed)
- Physicians who have not performed 1000 MSUS examinations.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Discovery learning (DL)DL makes the trainee practice before giving them instruction, "Do-Then-Tell", thereby promoting their ability to use and build upon their existing knowledge. | Other | MSUS experts |
Primary outcome
How do experts in MSUS approach a new and unfamiliar MSUS task?
Time frame: January 2023
All performances will be analyzed to examine how the experts solve the MSUS case, e.g., do they use the available material etc? More specifically, how much time (in seconds) do they use on different problem-solving methods such as "information seeking", "trial and error", and "systematic evaluation".
1 secondary outcome
How do the experts respond to DL?
Time frame: January 2023
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2023.
- Background: PubMed 35320441Brydges R, Fiume A, Grierson L. Mastery versus invention learning: impacts on future learning of simulated procedural skills. Adv Health Sci Educ Theory Pract. 2022 May;27(2):441-456. doi: 10.1007/s10459-022-10094-x. Epub 2022 Mar 23.
- Background: PubMed 31089856Steenhof N, Woods NN, Van Gerven PWM, Mylopoulos M. Productive failure as an instructional approach to promote future learning. Adv Health Sci Educ Theory Pract. 2019 Oct;24(4):739-749. doi: 10.1007/s10459-019-09895-4. Epub 2019 May 14.
- Background: PubMed 23696065Terslev L, Hammer HB, Torp-Pedersen S, Szkudlarek M, Iagnocco A, D'Agostino MA, Schmidt WA, Uson J, Bruyn GA, Filippucci E, Moller I, Balint P, Wakefield R, Naredo E. EFSUMB minimum training requirements for rheumatologists performing musculoskeletal ultrasound. Ultraschall Med. 2013 Oct;34(5):475-7. doi: 10.1055/s-0033-1335143. Epub 2013 May 21.
- Individual participant dataSharing planned: Undecided
Related trials for Musculoskeletal Diseases
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
RecruitingPhase 2
Study of PTC844 in Participants With Active Rheumatoid Arthritis
Rheumatoid Arthritis
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Not yet recruitingPhase 1
An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)
Rheumatoid Arthritis and Systemic Lupus Erythematosus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stine Maya Dreier Carstensen, MD principal investigator
COPECARE (Copenhagen Center for Arthritis Research) Rigshospitalet, Glostrup
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Musculoskeletal Diseases, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
How do experts in MSUS approach a new and unfamiliar MSUS task? (time frame: January 2023). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05639296, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2023.